DPP4 and myotonic dystrophy type 1: Additionally, although DPP-4 inhibitors are less likely to cause hypoglycemia [19], the risk of hypoglycemia with DPP-4 inhibitor use in patients with DM1, where hypoglycemia is observed even in untreated cases, has not yet been clarified.